reports
Dollar General Corp: 1 director
A director at Dollar General Corp sold 4,740 shares at 77.439USD and the significance rating of the trade was 58/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Akoya Biosciences and NeraCare Enter into an Exclusive Global License ...
Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions Akoya expands clinical test menu, exclusively licensing the global rights to develop and commercialize NeraCare's Immunoprint test for prognostication of disease recurrence in early-stage melanoma patients to better guide treatment decisions and potentially increase access to life saving therapies for those patients at high risk of developing metastatic disease MARLBOROUGH, Mass. and FRANKFURT...
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Ak...
Nature Methods Names Spatial Proteomics "Method of the Year 2024" — Akoya Biosciences Celebrates Industry Milestone MARLBOROUGH, Mass., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, announced that Nature Methods, one of the world’s leading scientific journals, has selected spatial proteomics as its prestigious , recognizing the transformative potential of this approach in advancing biological research and medicine. As a global leader in spatial proteomics, with the industry’s largest installed base of 1300 instruments and...
Northrim BanCorp, Inc. Appoints Shauna Hegna to its Board of Directors
Northrim BanCorp, Inc. Appoints Shauna Hegna to its Board of Directors ANCHORAGE, AK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) announced that Shauna Hegna has been appointed to its Board of Directors. “We are pleased to have Shauna join our Board,” said Joe Schierhorn, Chairman of the Board. “Shauna has extensive expertise in shareholder services, communications, and government affairs. Her proven leadership and accomplishments will be a notable addition to our Board of Directors.” Hegna has served as President of Koniag, an Alaska Native regional ...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per S...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per Share ANCHORAGE, Alaska, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.62 per share. The dividend will be payable on December 27, 2024, to shareholders of record at the close of business on December 19, 2024. “We are pleased to announce a quarterly dividend of $0.62 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price of $86.03 per sh...
BCB Bancorp, Inc. and BCB Community Bank Elect Michael J. Widmer to it...
BCB Bancorp, Inc. and BCB Community Bank Elect Michael J. Widmer to its Boards of Directors BAYONNE, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank” or “BCB”), today announced the election of Michael J. Widmer to the Board of Directors of both BCB Bancorp, Inc. and BCB Community Bank, effective December 4, 2024. Mr. Widmer has over 40 years of banking experience in New Jersey. He most recently worked as a bank consultant for BCB Community Bank where he aided management and staff on a variety of projects incl...
Akoya Biosciences Reports Third Quarter 2024 Financial Results
Akoya Biosciences Reports Third Quarter 2024 Financial Results MARLBOROUGH, Mass., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the third quarter ending September 30, 2024. “Our third-quarter results came in below expectations, largely due to ongoing capital equipment purchase constraints seen across the life science tools market. We remain optimistic about the long-term growth outlook of our industry, but we recognize the current environment will pose temporary challenges. We p...
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with...
Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode™ Discovery IO60 and Mouse FFPE IO Panel Pre-orders now available; early access available for select strategic partners for the PhenoCode IO60 panel – The Fastest Ultrahigh-plex Panel for Immuno-Oncology Research Launches the Mouse FFPE IO panel, optimized for pre-clinical immuno-oncology applications to drive translational research insights Expands the PhenoCode catalog with barcodes that enable ultrahigh-plex, 100-biomarker experiments, making scalable spatial biology research accessible for every lab M...
Northrim BanCorp Announces Acquisition of Sallyport Commercial Finance...
Northrim BanCorp Announces Acquisition of Sallyport Commercial Finance, LLC ANCHORAGE, Alaska, Nov. 01, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today announced the acquisition of Sallyport Commercial Finance, LLC (“Sallyport” or “SCF”) in an all cash transaction that closed on October 31, 2024 and is valued at approximately $53.9 million. Sallyport Commercial Finance, LLC is a leading provider of factoring, asset based lending and alternative working capital solutions to small and medium sized enterprises in the United States and Canada....
Akoya Bioscience to Report Third Quarter 2024 Financial Results on Nov...
Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 MARLBOROUGH, Mass., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced that it will release financial results for the third quarter of 2024 after the market closes on Thursday, November 14, 2024. Company management will host a conference call to discuss financial results at 5:00 p.m. ET. Investors interested in listening to the conference call are required to . It is recommended to register at least a day in ad...
Northrim BanCorp Earns $8.8 Million, or $1.57 Per Diluted Share, in Th...
Northrim BanCorp Earns $8.8 Million, or $1.57 Per Diluted Share, in Third Quarter 2024 ANCHORAGE, Alaska, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $8.8 million, or $1.57 per diluted share, in the third quarter of 2024, compared to $9.0 million, or $1.62 per diluted share, in the second quarter of 2024, and $8.4 million, or $1.48 per diluted share, in the third quarter a year ago. The increase in third quarter 2024 profitability as compared to the third quarter a year ago was primarily the result of an...
BCB Bancorp, Inc. Earns $6.7 Million in Third Quarter 2024; Reports $0...
BCB Bancorp, Inc. Earns $6.7 Million in Third Quarter 2024; Reports $0.36 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share BAYONNE, N.J., Oct. 18, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $6.7 million for the third quarter of 2024, compared to $2.8 million in the second quarter of 2024, and $6.7 million for the third quarter of 2023. Earnings per diluted share for the third quarter of 2024 were $0.36, compared to $0.14 in the preceding quarter and $0.39 in th...
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Groun...
Akoya’s Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy Consortium includes top universities, hospitals and industry partners, led by the Francis Crick Institute and The Royal Marsden NHS Foundation Trust Akoya’s platforms will be used for deep spatial proteomic profiling of thousands of tissue samples from cancer patients to identify biomarkers predicting treatment success MARLBOROUGH, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announc...
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of D...
Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors MARLBOROUGH, Mass., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), the Spatial Biology Company®, today announced Scott Mendel has been appointed as Chairman of its Board, effective October 2, 2024. Mr. Mendel succeeds Robert Shepler, founding Chairman, who will remain on Akoya’s board. Mr. Mendel has served as a member of Akoya’s board of directors since June 2021 and has over 30 years of financial and operational management experience. “I am thrilled to continue working wi...
BCB Bancorp, Inc. Completes Private Placement of $40.0 Million of Subo...
BCB Bancorp, Inc. Completes Private Placement of $40.0 Million of Subordinated Notes BAYONNE, N.J., Aug. 28, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), Bayonne, NJ (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today announced the completion of its private placement of $40.0 million in fixed-to-floating rate subordinated notes due 2034 (the “Notes”), to certain qualified institutional investors. The Notes initially bear a fixed rate of 9.250%, payable semi-annually, for the first five years and will reset quarterly thereafter to the then current ...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per S...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per Share ANCHORAGE, Alaska, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.62 per share. The dividend will be payable on September 13, 2024, to shareholders of record at the close of business on September 5, 2024. “We are pleased to announce a quarterly dividend of $0.62 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price o...
Akoya Biosciences Reports Second Quarter 2024 Financial Results
Akoya Biosciences Reports Second Quarter 2024 Financial Results MARLBOROUGH, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- . (Nasdaq: AKYA) (“Akoya”), The Spatial Biology Company®, today announced its financial results for the second quarter ending June 30, 2024. “Our second-quarter revenue showed a strong rebound with 26% sequential top-line growth and a stable year-over-year performance,” said Brian McKelligon, CEO of Akoya Biosciences. “We believe that Akoya’s platforms are poised to lead the spatial biology market from discovery to diagnostics, while we also position the company to achi...
Northrim BanCorp Earns $9.0 Million, or $1.62 Per Diluted Share, in Se...
Northrim BanCorp Earns $9.0 Million, or $1.62 Per Diluted Share, in Second Quarter 2024 ANCHORAGE, Alaska, July 24, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $9.0 million, or $1.62 per diluted share, in the second quarter of 2024, compared to $8.2 million, or $1.48 per diluted share, in the first quarter of 2024, and $5.6 million, or $0.98 per diluted share, in the second quarter a year ago. The increase in second quarter 2024 profitability as compared to the prior quarter and the second quarter a year ago was ...
BCB Bancorp, Inc. Earns $2.8 Million in Second Quarter 2024; Reports $...
BCB Bancorp, Inc. Earns $2.8 Million in Second Quarter 2024; Reports $0.14 EPS and Declares Quarterly Cash Dividend of $0.16 Per Share BAYONNE, N.J., July 19, 2024 (GLOBE NEWSWIRE) -- BCB Bancorp, Inc. (the “Company”), (NASDAQ: BCBP), the holding company for BCB Community Bank (the “Bank”), today reported net income of $2.8 million for the second quarter of 2024, compared to $5.9 million in the first quarter of 2024, and $8.6 million for the second quarter of 2023. Earnings per diluted share for the second quarter of 2024 were $0.14, compared to $0.32 in the preceding quarter and $0.50 in...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.